Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer

• Status: Recruiting
• Trial end date: 2024-06-30
• Target enrollment: 0
• Participant gender: Female

Summary

To develop a method of medical prevention of cardiovascular diseases caused by cardiotoxicity against the background of complex treatment of patients with primary resectable breast cancer to reduce the risk of cardiovascular complications

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: State Institution "Republican Scientific and Practical Center" Cardiology, Belarus
• Treatments: Bisoprolol; Perindopril; Ramipril

Criteria

Inclusion Criteria:

• women with breast cancer, with a morphologically confirmed diagnosis before the appointment of anticancer therapy.

Exclusion Criteria:

• presence of other oncological diseases